my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
28-03-2011: Seegene and Molzym announced a partnership on the automated Magicplex™ Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens.
"The Magicplex Sepsis Test will be the new gold standard for performing accurate, rapid and cost-effective sepsis diagnosis," said Dr. Jong-Yoon Chun, chief executive officer of Seegene. "In treating sepsis, time and accuracy are demanded. Every hour of delay in giving patients the correct antibiotics results in an 8% increase in the mortality rate."
“The automation reduces the total process costs significantly and makes Magicplex Sepsis Test the first true routine sepsis test worldwide” says Prof. Dr. Michael Lorenz, Chief Scientific Officer at Molzym.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
Seegene and Molzym partner on automated molecular sepsis diagnostics
Seegene and Molzym announced a partnership on the automated Magicplex™ Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens. "The Magicplex Sepsis Test will be the new gold standard for performing accurate, rapi ... more
Seegene Awarded Patent for Haplotyping Using Multiplex PCR
Seegene, Inc announced that it has been awarded international patent protection for a break-through technology able to accelerate the detection of highly personal variations in genetic sequences. These genetic variations can identify an individual's risks for a broad range of disorders, suc ... more
Seegene, Inc. announced that it has received a Medical Device License from Health Canada for its Seeplex(R) RV5 ACE (Auto Capillary Electrophoresis) Screening and RV12 ACE Detection tests. Built on the proprietary Seeplex(R) molecular diagnostic platform, the Canadian healthcare system can ... more
Seegene, Inc. is pioneering the field of multi-pathogen testing. Seegene applies its novel and proprietary Seeplex® system utilizing "DPO (Dual Priming Oligo)" and “ACP (Annealing Control Primer)” to create multi-pathogen tests delivering maximum specificity, reproducibility and sensitivity ... more
Seegene and Molzym partner on automated molecular sepsis diagnostics
Seegene and Molzym announced a partnership on the automated Magicplex™ Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens. "The Magicplex Sepsis Test will be the new gold standard for performing accurate, rapi ... more
Researchers identify non-culturable microbes from bloodstream infections
Molzym has developed in collaboration with NorDiag ASA the first automated platform worldwide for the culture-independent universal identification of microorganisms from whole blood. Clinical studies have shown that a high proportion of microbial infections are not detectable by conventiona ... more
Cooperation between NorDiag and Molzym
NorDiag and Molzym have now succeeded to combine their respective technologies into an integrated system for automated molecular detection of pathogens, among others for sepsis testing. Following this milestone, the two companies have signed a firm collaboration agreement regarding sale of ... more
Avoid DNA contaminations in your PCR assay. Molzym’s DNA-free water is a high quality PCR grade water, enabling a sensitive and reliable PCR. more
Quality for PCR: Highly-active Taq polymerase and mastermixes
PCR reagents for standard use and special PCR applications. Highly-active, robust PCR reagents for routine use more
New: Ultra-sensitive PCR reagents for Molecular Microbiology
Molzym offers a range of ultra-clean PCR products for 16S PCR. All kits are free of contaminating DNA enabling ultra-sensitive and reliable PCR-results more
Molzym is committed to producing innovative solutions for the molecular analysis of pathogens. Among Molzym‘s latest products are pre-analytic kits and diagnostic reagents and assays for the monitoring of bacterial agents of septic disease. The pre-analytic kits, MolYsis, are for the enri ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
